[ad_1]
Antibodies have developed in the bodies of everyone who participated in the initial test (experimental application) of the Russian coronavirus vaccine ‘Spunik-V’. The claim was made in a research report published in the world-renowned medical journal Lancet on Friday.
This is the first international publication on a Russian-made vaccine. Moscow sees the success of the vaccine as an appropriate response to critics, Reuters reported.
Russia announced on August 11 that it had approved the world’s first vaccine, Spinok-V, in an ongoing global competition to develop a safer vaccine for the coronavirus. The vaccine was named ‘Sputnik-V’ in honor of the Soviet spacecraft.
In announcing the approval of the vaccine, Russian President Vladimir Putin said it had also been applied to his daughter’s body.
However, shortly after the announcement, several countries began to express concern about the safety of the vaccine. The matter is also claimed to have been rushed and insufficient information has been released. Scientists from Germany, France, Spain and the United States have asked everyone to be vigilant.
“Two trials of the vaccine have been conducted over 42 days,” the Lancet report said.
On each occasion, 36 healthy volunteers and adults participated. The tests did not show any side effects in them, but it was confirmed that the antibodies were produced in their bodies.
Kirill Dimitriev, director of the Russian Direct Investment Fund (RDIF), a Russian health fund, said: “We have answered all the questions that the West has been asking for three weeks through this publication.” He accused them of trying to destroy the Russian vaccine.
“Now we are going to start questioning some Western vaccines,” Kirill Dimitriev said. The next test step with ‘Sputnik-V’ started from last week. Preliminary results are expected in October or November.
[ad_2]
